Cell Based Assay and Screening Technologies Conference 2013
November 6 - 8, 2013
San Francisco CA , USA
Dear Colleague,
We invite you to attend GTC’s 8th Cell Based Assay & Screening Technologies Conference on November 6-8, 2013 in San Francisco, CA. Over the past years, the field of assay technologies, laboratory automation, and informatics has taken great leaps forward. Present demands from the drug discovery process have propelled a shift in focus from high throughput screening to high content analysis, and there is a greater push for using iPS stem cells combined with 3D cell culture technologies for more physiologically relevant screen models. These developments have raised questions such as, what is the best model for screening for cell based assays? What is the payback of physiologically relevant systems?
Join us as we discuss these questions and explore how the field will move forward into the future. This meeting will connect industry leaders from major pharmaceutical companies, cutting-edge biotech companies and top researchers from academia and government to present innovative and relevant applications of current assay technologies to continually improve efficacy and meaningful data output and discuss the potential of novel analytical and screening technologies in drug discovery and development.
This year’s sessions include:
I. High Content & Image-Based Screening
II. Innovations in Phenotypic Screening
III. Advances in Functional Genomics & Screening
IV. Stem Cells & iPS Cells
V. 3D Cell Cultures & Physiologically Relevant Model Systems
This conference is a part of the larger 2nd Cancer Summit: Novel Approaches to Drug Discovery, which includes the co-located 3rd Cancer Epigenetics Conference. We encourage you to sign up for a summit pass for access to both tracks!
We look forward to seeing you at the conference!
Best regards,
The 2013 Advisory Committee
We invite you to attend GTC’s 8th Cell Based Assay & Screening Technologies Conference on November 6-8, 2013 in San Francisco, CA. Over the past years, the field of assay technologies, laboratory automation, and informatics has taken great leaps forward. Present demands from the drug discovery process have propelled a shift in focus from high throughput screening to high content analysis, and there is a greater push for using iPS stem cells combined with 3D cell culture technologies for more physiologically relevant screen models. These developments have raised questions such as, what is the best model for screening for cell based assays? What is the payback of physiologically relevant systems?
Join us as we discuss these questions and explore how the field will move forward into the future. This meeting will connect industry leaders from major pharmaceutical companies, cutting-edge biotech companies and top researchers from academia and government to present innovative and relevant applications of current assay technologies to continually improve efficacy and meaningful data output and discuss the potential of novel analytical and screening technologies in drug discovery and development.
This year’s sessions include:
I. High Content & Image-Based Screening
II. Innovations in Phenotypic Screening
III. Advances in Functional Genomics & Screening
IV. Stem Cells & iPS Cells
V. 3D Cell Cultures & Physiologically Relevant Model Systems
This conference is a part of the larger 2nd Cancer Summit: Novel Approaches to Drug Discovery, which includes the co-located 3rd Cancer Epigenetics Conference. We encourage you to sign up for a summit pass for access to both tracks!
We look forward to seeing you at the conference!
Best regards,
The 2013 Advisory Committee
+1 415 362 5500
Organizer
Related events
Cell Based Assay and Screening Technologies Conference October 7 - 8, 2014
Cell Based Assay and Screening Technologies Conference November 6 - 8, 2013
